Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 1534 of 3330
Next
>>
>
38326 to 38350 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
MCF 10F	NM	-	Ibandronate	FDPS	0.48	uM	12254.143	1.0423	1.0597	1.4110
MCF 10F	NM	-	Ibandronate	FDPS	2.4	uM	12254.143	1.0250	1.0353	1.4110
MCF 10F	NM	-	Ibandronate	FDPS	12	uM	12254.143	0.9297	0.8993	1.4110
MCF 10F	NM	-	Ibandronate	FDPS	60	uM	12254.143	0.7648	0.6538	1.4110
MCF 10F	NM	-	Ibandronate	FDPS	300	uM	12254.143	0.6115	0.4114	1.4110
MCF 10F	NM	-	Ibandronate	FDPS	1500	uM	12254.143	0.3718	-0.0080	1.4110
MCF12A	NM	Basal B	Ibandronate	FDPS	0.00384	uM	10817.143	1.0336	1.0425	1.5734
MCF12A	NM	Basal B	Ibandronate	FDPS	0.0192	uM	10817.143	0.9440	0.9281	1.5734
MCF12A	NM	Basal B	Ibandronate	FDPS	0.096	uM	10817.143	0.9942	0.9926	1.5734
MCF12A	NM	Basal B	Ibandronate	FDPS	0.48	uM	10817.143	0.9696	0.9612	1.5734
MCF12A	NM	Basal B	Ibandronate	FDPS	2.4	uM	10817.143	1.0520	1.0655	1.5734
MCF12A	NM	Basal B	Ibandronate	FDPS	12	uM	10817.143	0.9628	0.9524	1.5734
MCF12A	NM	Basal B	Ibandronate	FDPS	60	uM	10817.143	0.9272	0.9062	1.5734
MCF12A	NM	Basal B	Ibandronate	FDPS	300	uM	10817.143	0.6224	0.4797	1.5734
MCF12A	NM	Basal B	Ibandronate	FDPS	1500	uM	10817.143	0.2152	-0.2466	1.5734
MCF12A	NM	Basal B	Ibandronate	FDPS	0.00384	uM	12365.143	0.8967	0.9107	2.3865
MCF12A	NM	Basal B	Ibandronate	FDPS	0.0192	uM	12365.143	0.8831	0.8984	2.3865
MCF12A	NM	Basal B	Ibandronate	FDPS	0.096	uM	12365.143	0.9277	0.9381	2.3865
MCF12A	NM	Basal B	Ibandronate	FDPS	0.48	uM	12365.143	0.9300	0.9401	2.3865
MCF12A	NM	Basal B	Ibandronate	FDPS	2.4	uM	12365.143	0.9552	0.9619	2.3865
MCF12A	NM	Basal B	Ibandronate	FDPS	12	uM	12365.143	0.9130	0.9251	2.3865
MCF12A	NM	Basal B	Ibandronate	FDPS	60	uM	12365.143	0.7524	0.7753	2.3865
MCF12A	NM	Basal B	Ibandronate	FDPS	300	uM	12365.143	0.3765	0.3282	2.3865
MCF12A	NM	Basal B	Ibandronate	FDPS	1500	uM	12365.143	0.1790	-0.0273	2.3865
MCF7	HR+	Luminal	Ibandronate	FDPS	0.00384	uM	10997.143	1.0086	1.0270	0.6416

|<
<<
Previous
Page 1534 of 3330
Next
>>
>
38326 to 38350 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)